Correlation Between Estrella Immunopharma and Invivyd

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Invivyd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Invivyd into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and Invivyd, you can compare the effects of market volatilities on Estrella Immunopharma and Invivyd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Invivyd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Invivyd.

Diversification Opportunities for Estrella Immunopharma and Invivyd

-0.05

Correlation Coefficient

Estrella Immunopharma  Invivyd

Good diversification

The 3 months correlation between Estrella and Invivyd is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Invivyd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invivyd and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Invivyd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invivyd has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Invivyd go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Invivyd

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 3.12 times less return on investment than Invivyd. But when comparing it to its historical volatility, Estrella Immunopharma is 1.77 times less risky than Invivyd. It trades about 0.05 of its potential returns per unit of risk. Invivyd is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  46.00  in Invivyd on December 30, 2024 and sell it today you would earn a total of  14.00  from holding Invivyd or generate 30.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	58.06%
Values	Daily Returns

Estrella Immunopharma  vs.  Invivyd

Estrella Immunopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Invivyd

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Invivyd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Invivyd exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Estrella Immunopharma and Invivyd

The main advantage of trading using opposite Estrella Immunopharma and Invivyd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Invivyd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invivyd will offset losses from the drop in Invivyd's long position.

The idea behind Estrella Immunopharma and Invivyd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.